14.05.2013 • NewsEli LillyJohn LechleiterPeople

Eli Lilly CEO Recovering After Repair to Aorta

John Lechleiter, the longtime chief executive of Eli Lilly, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday.

"Dr. Lechleiter is recovering and will be closely monitored by the medical staff over the next several days," following his surgery on Monday, the Indianapolis company said in a statement.

Lilly Chief Financial Officer Derica Rice, 48, has taken on the additional role of acting CEO during Lechleiter's absence. The company last week said Lechleiter is expected to return to work this summer. Company officials could not immediately be reached on Tuesday.

Lechleiter, 59, had no symptoms of the condition, but learned of it during recent unrelated medical testing, Lilly said. The condition involves ballooning of the large artery that carries blood from the heart to all limbs and other organs, except the lungs.

Surgery is conducted to prevent rupture of the aorta, which can be life threatening.

 

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.